It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2022.
2022 | Nagpur, Maharashtra, India | ActiveQualicare Biopharm Private Limited, a active private limited company, was established on 21 February 2022 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2022PTC377225. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹7.00 Cr.
It upholds a compliant status. Its leadership includes Jagdish Ramesh Mangtani (Director), Rakesh Rameshkumar Hotchandani (Director), Sanjay Sachdev (Director). Past directors included Ritesh Nandlal Kewalramani, Anilkumar Ladharam Hasija. It holds ₹15.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S-4, Girish Heights, Commercial Complex, Bharat Talkis, Nagpur, Maharashtra, 440001.
U24230MH2022PTC377225
377225
21 February 2022
₹7.00 Cr
₹7.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Qualicare Biopharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagdish Ramesh Mangtani | Director | 21 Apr 2023 | Current |
| Rakesh Rameshkumar Hotchandani | Director | 21 Feb 2022 | Current |
| Sanjay Sachdev | Director | 21 Apr 2023 | Current |
| Chandan Pralhadrai Radhwani | Director | 21 Apr 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Jan 2024 | Past |
| Pramod Abcsdd | Director | 06 Dec 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Qualicare Biopharm's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Qualicare Biopharm's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹150,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2024 | Others | ₹15.00 Cr | Open |
Explore comprehensive loan charge details -
Qualicare Biopharm has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Qualicare Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qualicare Biopharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Qualicare Biopharm Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Qualicare Biopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100884011 was registered on 19 Mar 2024. was documented.
Progress on Jagdish Ramesh Mangtani was appointed as a Director was appointed as a Director on 21 Apr 2023 & has been associated with this company since 2 years 7 months . was documented.
Sanjay Sachdev was appointed as a Director was appointed as a Director on 21 Apr 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The activity Chandan Pralhadrai Radhwani was appointed as a Director was appointed as a Director on 21 Apr 2023 & has been associated with this company since 2 years 7 months . was completed.
The CIN of Qualicare Biopharm Private Limited is U24230MH2022PTC377225.
Qualicare Biopharm Private Limited is headquartered at S-4, Girish Heights, Commercial Complex, Bharat Talkis, Nagpur, Maharashtra, 440001.
Qualicare Biopharm Private Limited was incorporated on 21 February 2022.
The current directors of Qualicare Biopharm Private Limited are
The primary industry of Qualicare Biopharm Private Limited is Pharma.
Qualicare Biopharm Private Limited is unlisted.
The authorized capital of Qualicare Biopharm Private Limited is ₹7.00 Cr, and the paid-up capital is ₹7.00 Cr.
The compliance status of Qualicare Biopharm Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX